S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
NYSE:AVTR

Avantor Stock Competitors

$38.13
-0.14 (-0.37%)
(As of 12/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$37.48
$38.38
50-Day Range
$36.93
$41.55
52-Week Range
$26.14
$44.37
Volume
2.71 million shs
Average Volume
4.04 million shs
Market Capitalization
$23.24 billion
P/E Ratio
48.27
Dividend Yield
N/A
Beta
1.6

Avantor (NYSE:AVTR) Vs. ILMN, A, MTD, PKI, BIO.B, BIO, WAT, TXG, BRKR, and COHR

Should you be buying Avantor stock or one of its competitors? The main competitors of Avantor include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Waters (WAT), 10x Genomics (TXG), Bruker (BRKR), and Coherent (COHR). These companies are all part of the "analytical instruments" industry.

Avantor vs.

Avantor (NYSE:AVTR) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings, community ranking and institutional ownership.

Avantor has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.

Agilent Technologies received 683 more outperform votes than Avantor when rated by MarketBeat users. However, 77.36% of users gave Avantor an outperform vote while only 74.77% of users gave Agilent Technologies an outperform vote.

CompanyUnderperformOutperform
AvantorOutperform Votes
123
77.36%
Underperform Votes
36
22.64%
Agilent TechnologiesOutperform Votes
806
74.77%
Underperform Votes
272
25.23%

In the previous week, Agilent Technologies had 14 more articles in the media than Avantor. MarketBeat recorded 19 mentions for Agilent Technologies and 5 mentions for Avantor. Agilent Technologies' average media sentiment score of -0.04 beat Avantor's score of -0.17 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilent Technologies
2 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Avantor presently has a consensus target price of $45.19, indicating a potential upside of 18.51%. Agilent Technologies has a consensus target price of $153.17, indicating a potential upside of 1.12%. Given Avantor's stronger consensus rating and higher probable upside, equities analysts plainly believe Avantor is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
3.00
Agilent Technologies
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.93

90.9% of Avantor shares are held by institutional investors. 2.0% of Avantor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Agilent Technologies has a net margin of 19.15% compared to Avantor's net margin of 7.07%. Avantor's return on equity of 39.88% beat Agilent Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor 7.07% 39.88% 7.92%
Agilent Technologies 19.15% 26.71% 12.91%

Agilent Technologies has lower revenue, but higher earnings than Avantor. Agilent Technologies is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.39 billion3.63$116.60 million$0.7948.27
Agilent Technologies$6.32 billion7.26$1.21 billion$3.9438.44

Summary

Avantor beats Agilent Technologies on 10 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

Avantor (NYSE:AVTR) vs. Its Competitors

TypeAvantorAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$23.24B$8.21B$4.86B$15.31B
Dividend YieldN/A0.29%2.04%3.22%
P/E Ratio48.2711.2322.9923.08
Price / Sales3.6355.132,379.0531.59
Price / Cash22.7240.4561.7487.33
Price / Book7.4913.796.007.66
Net Income$116.60M$332.54M$95.76M$383.46M
7 Day Performance-3.42%-4.84%-4.27%0.35%
1 Month Performance-0.13%-16.26%-13.77%-6.38%
1 Year Performance38.60%27.89%7.13%24.06%

Avantor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ILMN
Illumina
2.0364 of 5 stars
$351.65
-1.2%
$443.20
-26.0%
+0.3%$54.96B$3.24B57.747,850
A
Agilent Technologies
2.4876 of 5 stars
$151.47
-1.4%
$153.17
-1.1%
+31.5%$45.85B$6.32B38.4416,400Insider Selling
MTD
Mettler-Toledo International
1.9081 of 5 stars
$1,535.50
-0.4%
$1,410.33
-8.2%
+35.7%$35.30B$3.09B48.1216,500
PKI
PerkinElmer
2.3881 of 5 stars
$181.48
-0.9%
$155.31
-14.4%
+28.0%$22.90B$3.78B18.0614,000
BIO.B
Bio-Rad Laboratories
1.3565 of 5 stars
$750.16
-0.0%
N/A+34.8%$22.44B$2.55B3.408,000
BIO
Bio-Rad Laboratories
2.2631 of 5 stars
$742.36
-0.1%
$801.67
-8.0%
+32.7%$22.21B$2.55B3.378,000
WAT
Waters
1.7374 of 5 stars
$336.33
-1.5%
$367.00
-9.1%
+41.5%$20.53B$2.37B30.167,400
TXG
10x Genomics
2.4229 of 5 stars
$135.05
-2.1%
$174.14
-28.9%
-9.4%$15.09B$298.85M-31.93852
BRKR
Bruker
2.6448 of 5 stars
$78.73
-0.4%
$78.86
-0.2%
+46.7%$11.94B$1.99B44.487,400
COHR
Coherent
1.4398 of 5 stars
$260.59
-0.7%
$234.20
-10.1%
+89.5%$6.43B$1.49B-59.094,875Analyst Downgrade
PACB
Pacific Biosciences of California
2.1348 of 5 stars
$20.19
-1.4%
$50.00
-147.6%
+0.0%$4.45B$78.89M-96.14412
CTKB
Cytek BioSciences
1.5548 of 5 stars
$18.93
-0.3%
$27.33
-44.4%
N/A$2.53BN/A0.002,021
OLK
Olink Holding AB (publ)
1.5481 of 5 stars
$18.66
-0.9%
$40.50
-117.0%
N/A$2.22B$54.07M0.00214
HLTH
Cue Health
0 of 5 stars
$10.72
-6.9%
N/AN/A$1.57BN/A0.001,254Gap Down
QTRX
Quanterix
2.1265 of 5 stars
$38.64
-2.8%
$66.00
-70.8%
-17.6%$1.42B$86.38M-28.41314
BLI
Berkeley Lights
2.4248 of 5 stars
$19.27
-1.2%
$56.75
-194.5%
-76.3%$1.30B$64.30M-19.27230
BNGO
Bionano Genomics
2.0381 of 5 stars
$3.34
-1.8%
$12.33
-269.3%
+565.6%$965.88M$8.50M-13.92147Gap Down
OMIC
Singular Genomics Systems
1.5998 of 5 stars
$11.48
-6.2%
$30.33
-164.2%
N/A$827.24MN/A0.00138Short Interest ↑
News Coverage
NAUT
Nautilus Biotechnology
2.1331 of 5 stars
$4.95
-2.2%
$11.50
-132.3%
N/A$614.63MN/A0.0082
EYPT
EyePoint Pharmaceuticals
2.3264 of 5 stars
$14.54
-0.1%
$22.38
-53.9%
-71.9%$492.82M$34.44M-5.82100
AKYA
Akoya Biosciences
1.9931 of 5 stars
$12.74
-2.6%
$25.50
-100.2%
N/A$474.03M$42.44M0.00169Short Interest ↓
Gap Down
RPID
Rapid Micro Biosystems
1.6399 of 5 stars
$9.94
-18.4%
$27.33
-175.0%
N/A$411.05M$16.08M0.002,021
FLDM
Fluidigm
2.0333 of 5 stars
$4.25
-0.9%
$7.00
-64.7%
-30.8%$325.07M$138.14M-4.72627
ISO
IsoPlexis
1.7 of 5 stars
$8.02
-29.3%
$20.00
-149.4%
N/A$312.42MN/A0.002,021
AXDX
Accelerate Diagnostics
2.7314 of 5 stars
$4.77
-4.2%
$9.00
-88.7%
-36.7%$293.35M$11.16M-3.82224
HBIO
Harvard Bioscience
2.3948 of 5 stars
$6.64
-0.6%
$9.00
-35.5%
+69.4%$270.99M$102.10M-132.80444
DNAY
Codex DNA
1.7998 of 5 stars
$6.41
-0.2%
$23.19
-261.8%
N/A$187.86MN/A0.00101
TLIS
Talis Biomedical
2.2115 of 5 stars
$4.86
-4.1%
$12.00
-146.9%
N/A$127.77M$10.94M0.00135
PRPO
Precipio
2.0198 of 5 stars
$1.80
-2.2%
$7.00
-288.9%
-24.1%$40.87M$6.09M0.0056
ASTC
Astrotech
1.1981 of 5 stars
$0.73
-2.7%
N/A-59.5%$36.14M$330K0.0027
SQL
SeqLL
0 of 5 stars
$2.52
-5.6%
N/AN/A$29.95M$330K0.00N/ANegative News
This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.